SE8600742D0 - METHOD OF TREATMENT - Google Patents

METHOD OF TREATMENT

Info

Publication number
SE8600742D0
SE8600742D0 SE8600742A SE8600742A SE8600742D0 SE 8600742 D0 SE8600742 D0 SE 8600742D0 SE 8600742 A SE8600742 A SE 8600742A SE 8600742 A SE8600742 A SE 8600742A SE 8600742 D0 SE8600742 D0 SE 8600742D0
Authority
SE
Sweden
Prior art keywords
alkoxy
aryl
alkyl
contg
opt
Prior art date
Application number
SE8600742A
Other languages
Swedish (sv)
Other versions
SE8600742A0 (en
SE8600742L (en
Inventor
A E Brendstrom
P L Lindberg
G E Sunden
B M G Wallmark
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of SE8600742D0 publication Critical patent/SE8600742D0/en
Publication of SE8600742A0 publication Critical patent/SE8600742A0/en
Publication of SE8600742L publication Critical patent/SE8600742L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Treatment comprises administering a 2- (1-2-pyridyl) alkylsulphinyl) -benzyimidazole of formula (I) or its salt: R1-R4 = H, halogen, CN, CF3, -COR11, -O-CO-R12, -CH(OR13)2, -(Z)n-A-D, up to 10C aryl, up to 10C aryloxy, 1-6C alkylthio, NO2 or 1-6C alkylsulphinyl, or two of R1-R4 can together form a fixed 5-7 membered monocyclic or 9-11 membered bicyclic (un)satd. ring contg. 0-3 O or N heteroatoms, opt. substd. or R1, R2, R2/R3 or R3/R4 can complete two rings opt. fused with each other; R11 and R12 = up to 10C aryl, 1-4C alkoxy, 1-3C alkoxy 1-3C alkoxy, (up to 10C)aryl-(1-20) alkoxy, up to 10C aryloxy, di-(1-3C) alkylamino, or pyrrolidino or piperidino both opt. substd. ; R13 = 1-4C alkyl or 2-3C alkylene; Z = O or CO; n = 0 or 1; A = 1-6C alkylene, 3-6C cycloalkylene, 2-6C alkylene, 3-6C cycloalkylene or 2-6C alkynylene; D = H, CH (sic), -CO-R9 or -(Y)-(CO)r-R10; R9 = 1-5C alkoxyor di(1-3C) alkylamino; m and r = 0 or 1; Y = O or NR10; R10 = H, 1-3C alkyl, (up to 10C) aryl -(1-2C) alkyl or up to 10C aryl; R5 = H, CH3 or C2H5; R6 and R8 = H or 1-6C alkyl; R7 = H, 1-8C alkyl, 1-8C alkoxy, 2-5C alkenyloxy, 2-5C alkynyloxy, (1-2C) alkoxy (1-2C) alkoxy, (up to 10C) aryl-(1-6C)alkyl, up to 10C aryloxy (opt. substd.), (up to 10C) aryl (1-6C) alkoxy, di-(1-2C) alkylamino-(1-4C) alkoxy, oxycycloalkyl contg. one O and 3-7C, oxacycloalkoxy contg. two O and 4-7C, oxacycloalkylalkyl contg. one O and 4-7C or oxacycloalkylalkoxy contg. one O and 4-7C; or R6 + R7 or R7 + R8 = -CH=CH-CH=CH-, -O(CH2)p- -S(CH2)v-, -CH2(CH2)p-, -O-CH=CH-, -NH-CH=CH- or -N(Me)-CH=CH-p=2-4; v=2,3.
SE8600742A 1985-03-01 1986-02-19 TREATMENT SE8600742L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8500995A SE8500995D0 (en) 1985-03-01 1985-03-01 METHOD OF TREATMENT

Publications (3)

Publication Number Publication Date
SE8600742D0 true SE8600742D0 (en) 1986-02-19
SE8600742A0 SE8600742A0 (en) 1986-09-02
SE8600742L SE8600742L (en) 1986-09-02

Family

ID=20359317

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8500995A SE8500995D0 (en) 1985-03-01 1985-03-01 METHOD OF TREATMENT
SE8600742A SE8600742L (en) 1985-03-01 1986-02-19 TREATMENT

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8500995A SE8500995D0 (en) 1985-03-01 1985-03-01 METHOD OF TREATMENT

Country Status (1)

Country Link
SE (2) SE8500995D0 (en)

Also Published As

Publication number Publication date
SE8500995D0 (en) 1985-03-01
SE8600742A0 (en) 1986-09-02
SE8600742L (en) 1986-09-02

Similar Documents

Publication Publication Date Title
IL98991A0 (en) Derivatives of benzofuran,benzothiophene,indole and indolizine,their preparation and pharmaceutical compositions containing them
FR2651122B1 (en) COMPOSITIONS FOR USE IN BRAKING HAIR LOSS AND INDUCING AND STIMULATING THEIR GROWTH, CONTAINING 2-AMINO PYRIMIDINE OXIDE-3 DERIVATIVES AND NEW AMINO-2 PYRIMIDINE OXIDE-3 DERIVATIVES.
SG44837A1 (en) New amidine derivatives the preparation and use thereof as pharmaceutical compositions with ltb4-antagonistic activity
CY1549A (en) Naphthoquinone derivatives
ES8604571A1 (en) Indole-3-carboxamide derivatives.
SE8600742D0 (en) METHOD OF TREATMENT
ES8601963A1 (en) (1H-tetrazol-5-yl)-2(1H)-quinolinones.
SE8400688D0 (en) NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS
PT86230A (en) Process for preparing tricyclic ketones substituted with imidazolylmethyl
FR2197513A2 (en) Heterocyclic organophosphorus insecticides - and acaracides contg. 1,2-fused-6-pyrinidone ring
IT1229614B (en) Substd. triazolo pyrimidine(s)
IT1230754B (en) New 1-heterocyclyl-2-amino-ethanol cpds.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8600742-4

Effective date: 19870423

Format of ref document f/p: F